Statistics

Total Visits

Views
A randomised, double-blind, parallel-group, phase 1 study comparing the pharmacokinetics, safety and efficacy of ct-p13 and infliximab in patients with active ankylosing spondylitis: 54 week results from the planetas study101

Select a period of time:

Number of views in the range

Views
A randomised, double-blind, parallel-group, phase 1 study comparing the pharmacokinetics, safety and efficacy of ct-p13 and infliximab in patients with active ankylosing spondylitis: 54 week results from the planetas study25

Views

Views
October 20252
November 20256
December 20255
January 20265
February 20260
March 20267
April 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States12
Brazil7
United Kingdom2
Canada1
India1
Taiwan1
Venezuela1
 

Top cities views

Views
San Jose4
Ashburn4
Caracas1
Caxias do Sul1
Chennai1
Curitiba1
Montreal1
Phoenix1
Piúma1
Rio de Janeiro1